INTRODUCTION
============

Secondary lymphoid organs/tissues (SLOs) are essential for the efficient induction of adaptive immune responses. Several types of SLOs, including the lymph nodes (LNs), spleen, and mucosal-associated lymphoid tissues (MALTs) such as Peyer's patches (PPs), are strategically positioned throughout various places within the body. SLOs are an elaborate filter that samples antigens and is equipped with highly sensitive immune sensors. In order to collect and filtrate foreign antigens, SLOs contain specialized tissue structures that are associated with the endothelium or epithelium. Immune cells such as lymphocytes, dendritic cells (DCs), and macrophages accumulate to high densities and form compartments. A remarkable feature common to all SLOs is the segregated localization of B cells and T cells. The architecture of SLOs is supported by several types of non-hematopoietic stromal cells of mesenchymal origin, which construct networks and define compartments ([@B41]; [@B48]). Stromal networks provide not only a functional foothold but also a space for immune cell activities, as well as a physical framework for the tissue. Moreover, growing evidence indicates that stromal cells also play critical roles in immune cell function and homeostasis ([@B31]; [@B16]; [@B53]; [@B32]). SLOs are programmed to develop from the anlagen that occur at certain places and during restricted periods in the fetus and infant. In addition, stromal cells are known to be important for SLO development and maintenance ([@B38]). Here, I focus on a recently identified stromal subset, marginal reticular cells (MRCs), and summarize their characteristics. I also discuss the relationship between MRCs and tissue structure, other stromal subsets, and immunological functions.

T AND B CELL COMPARTMENTS AND TWO CONVENTIONAL STROMAL CELL SUBSETS
===================================================================

As described above, B cells and T cells localize to distinct regions within SLOs. B cells accumulate to form follicles (B zone) in the outer cortex beneath the capsule in LNs or in the outer periarteriolar lymphoid sheath (PALS) in the spleen. A cluster of large follicles is the core tissue of PPs. During immune responses, activated B cells in the follicles form germinal centers, where they differentiate into high-affinity antibody producers ([@B11]). In contrast, T cells localize to a separate area (T zone) adjacent to the follicles, i.e., the paracortex in LNs, inner PALS in the spleen, or interfollicular region (IFR) in PPs. DCs also accumulate in the T zone to present antigen and prime T cells ([@B51]).

There are two different types of mesenchymal stromal subsets in the B and T zones (**Figure [1A](#F1){ref-type="fig"}**). Follicular dendritic cells (FDCs) form a dense network in the center of the follicles and have received considerable attention because of their importance in antibody production by B cells ([@B57]; [@B11]; [@B61]; [@B53]). FDCs express CR1/CD35, CD23, and occasionally MAdCAM-1 ([@B54]; [@B11]). By contrast, an elaborate network of fibroblastic reticular cells (FRCs) comprises the scaffold of the T zone, which produces podoplanin/gp38 and various extracellular matrix (ECM) components ([@B17]; [@B33]; [@B21]; [@B22],[@B23]). In general, immune cell migration and localization are regulated by a variety of chemokines ([@B35]). Resting lymphocytes and mature DCs are highly responsive to "homeostatic chemokines" ([@B10]; [@B42]). Consistent with this, there are clear correlations between chemokines produced by stromal cell subsets and the localization of immune cells expressing the corresponding receptors; CXCL13 produced by FDCs is an attractant of B cells expressing CXCR5, while CCL19 and CCL21 from T zone FRCs attract T cells and mature DCs through the common receptor CCR7 ([@B10]; [@B11]; [@B33]). Moreover, lymphocytes that migrate robustly in the tissue parenchyma to scan antigens are thought to use stromal networks as a foothold ([@B1]). A variety of factors produced by stromal subsets are also required for the activation and survival of immune cells ([@B11]; [@B20]; [@B31]; [@B53]; [@B32]; [@B36]). Therefore, the structure and function of the stromal network in each compartment is likely optimized for the activity of immune cell subsets.

![**Stromal cell subsets and tissue structures of SLOs.** **(A)** Schematic representation of tissue structures in mouse SLOs, with an emphasis on stromal cells and the antigen-transporting apparatus. Stromal elements, including mesenchymal, endothelial, and epithelial cells as well as myeloid cells such as macrophages and dendritic cells (listed in the right panel), are drawn for emphasis. **(B)** Upper: The tissue framework constructed by three different types of stromal cells in the outer cortical region of LN. Fluorescent immunostaining of a mouse LN section. In the upper micrograph, there is a small resting follicle (B) without a germinal center, which is supported by FDCs expressing CR1/CD35 but undetectable levels of CXCL13. Instead, MRCs form a laminin^+^CXCL13^+^ reticular network in the outer edge of the follicle underneath the capsule (CA) and SCS. The network constructed by FRCs in the paracortex (T) is laminin^+^CXCL13^-^CR1/CD35^-^. Lower: MAdCAM-1^+^ MRC layer is closely associated with LYVE-1^+^ lymphatic endothelial layer in the SCS. Note that MRC layer is extended to the IFC area.](fimmu-03-00200-g001){#F1}

The stromal network in the T zone is composed of FRCs and an ECM bundle known as a reticular fiber, which forms a "conduit" that facilitates the passage of low molecular weight substances ([@B17], [@B18]; [@B43]). This conduit transports various factors and soluble antigens deep within the tissue, while particles and large molecules are predominantly excluded from the lymphocyte compartments. Indeed, lymph-borne chemokines from peripheral tissues are rapidly transported to the high endothelial venule through the conduit to control the mobilization of circulating cells into the LNs ([@B45]). In addition, some resident DCs directly contact the conduit and capture lymph-borne antigens ([@B50]).

A NEWLY IDENTIFIED STROMAL SUBSET, MARGINAL RETICULAR CELLS
===========================================================

The outer margin of the LN cortex, just beneath capsule, is surrounded by the subcapsular sinus (SCS; **Figure [1A](#F1){ref-type="fig"}**). The luminal surface of the SCS is covered with lymphatic endothelial cells and their cortical side is backed by the basement membrane, called the "floor" ([@B55]). Particularly within the IFRs, reticular fibers spread out from the floor into the paracortex ([@B17]). Importantly, a thin layer of reticular structure is also observed in the outermost region of the follicles. FRC-like stromal cells in the follicular reticulum express CXCL13 and MAdCAM-1 but not CCL21, which indicates that these cells are distinct from T zone FRCs, while the FDC marker CR1/CD35 was undetected or only weakly expressed in these cells ([@B25]; **Figures [1B](#F1){ref-type="fig"} and [2A](#F2){ref-type="fig"}**). FDCs do not generate reticular fibers, and accordingly, the reticular marker ER-TR7 is virtually absent in the center of the follicles ([@B22],[@B23]). In addition, reticular cells in the subcapsular region specifically express RANKL/TRANCE, which is a TNF family cytokine that is essential for LN development ([@B12]; [@B29]). Therefore, these stromal cells were thought to be a new stromal subset and were designated marginal reticular cells (MRCs; [@B25]). Of note, a substantial amount of CXCL13 is constitutively expressed in MRCs in resting small follicles even if FDCs express undetectable levels of CXCL13 (**Figure [1B](#F1){ref-type="fig"}**). It is well established that the outer edge of PALS in the spleen, especially that which lies over the follicles, is bordered by a MAdCAM-1^+^ stromal layer. The cells that constitute the lining of basement membrane beneath the marginal sinus (MS) also express CXCL13 and RANKL, indicating that these cells are a type of MRCs ([@B25]). In MALTs, reticular cells similar to MRCs form a network in the subepithelial dome (SED) region just under the basement membrane of the follicle-associated epithelium (FAE; [@B25]; [@B27]). Taken together, MRCs are thought to be a stromal subset common to SLOs but distinct from FDCs and FRCs.

![**Relationship between MRCs and other stromal cell subsets in SLOs.** **(A)** Pattern of marker expression in stromal cell subsets. Expression levels of MAdCAM-1, CXCL13, and podoplanin/gp38 in FDCs are often weak or undetectable by immunohistochemistry (†). **(B)** Schematic of a generalized model of SLO development with the locations of stromal cell subsets (left) and a putative genealogy of stromal cell subsets (right). Numbers indicating cell elements in the left drawing represent stromal cell subsets shown in the right scheme. BM, basement membrane; End./Epi., endothelial or epithelial layer.](fimmu-03-00200-g002){#F2}

MRCs AND THE ANTIGEN ENTRY ROUTE IN SLOs
========================================

Secondary lymphoid organs are characterized by peculiar structures that filtrate and transport antigens into the lymphocyte compartments (**Figure [1A](#F1){ref-type="fig"}**). LNs are connected with lymphatic vessels to survey lymph-borne antigens. Because the afferent lymphatics are open to the SCS, the sinus lymphatic endothelium and floor basement membrane are, as it were, the front surface of the LN filter. The spleen filters blood, in which branches of the central artery open to the MS and marginal zone (MZ), where immune cells survey the blood contents. In these specialized sinus structures, the border barriers are the lymphatic endothelium in the SCS of the LN and the blood endothelium in the MS of the spleen, both of which are supported by the MRC reticulum. Interestingly, CD169^+^ metallophilic macrophages are selectively distributed near the sinus lining over the follicles, some of which settle across the endothelial barrier and convey particulate antigens from the sinus lumen into the lymphocyte compartment ([@B55]; [@B56]; [@B6]; [@B46]). DCs that carry antigens from the tissues via the lymphatic vessels arrive at the SCS and subsequently move into the paracortex across the floor of the interfollicular channel (IFC; [@B51]; [@B23]; [@B5]). In MALTs, the FAE functions as the barrier in which a specialized epithelial cell called M cells transfers bacteria or particles from the gut lumen to underlying DCs or macrophages ([@B30]). Therefore, MRCs support the frontline antigen-transporting apparatus in each SLO. The basic design of SLOs is that the follicles are primarily arranged toward the site of antigen entry and are accompanied by T zones. Thus, from a stromal viewpoint, the whole tissue architecture appears to be organized toward the MRC layer.

Although the immunological functions of MRCs remain elusive, it was previously shown that the conduit network constructed by MRCs in the outer follicle transports small soluble antigens to follicular B cells and FDCs ([@B2]; [@B47]). Most CD169^+^ macrophages are positioned at the cortical side of the SCS floor and protrude an extension into the sinus lumen to capture particles ([@B46]). Thus, MRCs might be involved in the localization, morphology, and function of these macrophages. M cell development in PPs requires RANKL-RANK signaling, which is likely controlled by a RANKL-expressing MRC network just beneath the FAE ([@B27]). Inhibiting the LT pathway, which abolishes MRC signatures in the splenic white pulp, disturbs the MS structure ([@B28]; [@B3]; [@B25]; [@B62]). Moreover, elevated ICAM-1, VCAM-1, and CXCL13 expression implies that MRCs are involved in the dynamic interstitial migration of follicular B cells as a functional scaffold. CD169^+^ macrophages have been shown to directly deliver particulate antigens to antigen-specific B cells in this area ([@B6]; [@B46]), suggesting that MRC network-mediated control of B cell migration may impact this process. Since MRCs are also present in the IFC region, they possibly regulate the transmigration of DCs from the SCS toward the T zone.

MRCs AND ORGANIZER STROMAL CELLS IN SLO DEVELOPMENT
===================================================

Secondary lymphoid organs develop from the anlagen, which are aggregates of mesenchymal and hematopoietic cells associated with vessels or epithelium, at a defined site and period in the fetus or infant ([@B38]). A critical event in the development of the SLO anlagen is the accumulation of CD45^+^CD4^+^CD3^-^ hematopoietic cells, which are also known as lymphoid tissue inducer (LTi) cells that interact with mesenchymal stromal cells called lymphoid tissue organizer (LTo) cells ([@B37]). A TNF family cytokine, lymphotoxin (LT)-α1β2 that is expressed by LTi cells transmits signals to LTo cells via the LT-β receptor. LTo cells subsequently induce the expression of adhesion molecules, including ICAM-1, VCAM-1, and MAdCAM-1, and chemokines CXCL13, CCL19, and CCL21 ([@B19]; [@B8]; [@B4]). In particular, CXCL13 is especially important in attracting LTi cells to the anlagen via its receptor CXCR5 ([@B15]; [@B34]; [@B44]). It is assumed that a positive feedback loop, i.e. newly immigrating LTi cells that produce LT further activate LTo stromal cells, promoting the organization of the anlagen. As lymphocytes began to accumulate after birth, the tissue expands and the compartments supported by different stromal cell subsets are induced ([@B9]; [@B2]).

Marginal reticular cells and LTo cells express a very similar pattern of various markers (**Figure [2A](#F2){ref-type="fig"}**), suggesting that there is some relationship between these two stromal cells. LTo cells seem to be more concentrated in the marginal region of the LN anlagen adjacent to the lymphatic sinus of the presumptive SCS ([@B15]; [@B8]; [@B14]; [@B25]). This LTo cell layer appears to expand outwardly with the growth of the anlagen, which ultimately appears to become the MRC layer ([@B25]). Likewise, as lymphocytes accumulate around the central artery in the postnatal spleen, LTo cells expressing MAdCAM-1 and RANKL expand with the layer and become MRCs in the white pulp. These findings strongly suggest that MRCs are a direct descendant of the LTo stroma, which preserve the characteristics of LTo cells at specialized sites within SLOs. Even RAG-deficient mice exhibit a subcapsular MRC layer in atrophic LNs and shrunken periarterial MRC sheathes in the spleen, indicating that MRC development occurs independently of B and T cells and is programmed before their colonization ([@B25]). Since SLOs efficiently sample antigens to trigger immune responses, the antigen-collecting structures that are constructed during development need to be maintained thereafter. Accordingly, it is reasonable that these tissue structures are maintained by organizer-like stromal cells throughout adulthood.

RELATIONSHIP BETWEEN MRCs AND OTHER STROMAL SUBSETS
===================================================

**Figure [2B](#F2){ref-type="fig"}** shows the possible genealogy of stromal subsets in SLOs. In the embryo, the primordial mesenchyme that is in close proximity to the vasculature or epithelium is committed to form the anlage core and attracts LTi cells. Nerve cells or other less characterized cells are also involved in the initial process ([@B60]; [@B59]). The accumulation of LTi cells facilitates the maturation of mesenchymal cells into LTo cells, which ultimately facilitates the construction of the basic architecture. Typically, LTo cells tend to concentrate at the periphery of the anlage and expand outward with tissue growth, while stromal cells exhibiting weak or no LTo signatures conversely increase in the inner portion of the anlage. Postnatal colonization of B and T cells leads to compartments with the induction of conventional stromal subsets.

If this scheme is correct, it follows that all the stromal subsets in adult SLOs are originally derived from LTo cells. Thus, do MRCs that preserve the characteristics of LTo cells have the ability to differentiate into FDCs or FRCs? MRCs share many signatures with other subsets (**Figure [2A](#F2){ref-type="fig"}**), suggesting that this is possible. One speculation is that MRCs function as stromal stem cells that continuously supply all of the stromal subsets throughout adulthood. Although this idea is intriguing, it will require cautious consideration and further validation in the future. Mesenchymal cells are generally highly flexible in nature depending on the surrounding environment, and thus specific features can be easily changed. Extended culturing of stromal cells isolated from LNs results in lost expression for many genes, particularly homeostatic chemokines ([@B22]; [@B58]). This suggests that the *in vivo* phenotypes of stromal cell subsets are optimally maintained by the tissue circumstances, which are reversible and not due to terminal differentiation. In addition, inflammatory stimuli induce the robust proliferation of stromal cells and the dramatic remodeling of SLOs ([@B22]; [@B7]). Therefore, although MRCs could be converted to other subsets, conventional stromal subsets might also self-renew and be interchangeable in adult SLOs.

REMODELING OF SLOs AND TERTIARY LYMPHOID STRUCTURES
===================================================

During immune responses, stromal structures within SLOs are dramatically remodeled ([@B17]; [@B22]). Some infections cause a severe disruption of tissue structures within the LNs and splenic white pulp within a few days, which is restored as the pathogens are eradicated ([@B39],[@B40]; [@B49]; [@B52]). This restoration process likely recapitulates a self-organizing process via a feedback reaction similar to SLO development. Importantly, LTi-like cells are also present in adult tissues and regulate infection-associated remodeling of SLOs ([@B26]; [@B49]). Although the role of MRCs in such processes is unknown, they possibly have an organization role in collaboration with LTi-like cells and determine the outer frame of SLOs during reconstruction.

In chronic inflammation associated with various organ pathologies, large numbers of infiltrating lymphocytes often lead to organizations that are similar to SLOs, known as tertiary lymphoid tissues (TLTs; [@B13]). B and T cells are segregated and corresponding networks of stromal cell subsets are induced. It would be interesting to determine whether MRCs are present in these ectopic lymphoid structures; however, MRC-like cells and related tissue structures are not observed in TLTs that developed during mouse autoimmune gastritis ([@B24], [@B25]). It should be emphasized that TLTs are fundamentally not programmed lymphoid organizations and naturally do not associate with the antigen-transporting structures. Therefore, MRCs are likely absent in TLTs. Even though stromal cells that are phenotypically similar to MRCs might be induced in some lesions, they would not be identified as MRCs unless they closely associate with the specific endothelial or epithelial structure and form a layered reticulum at the outer follicles.

CONCLUSION
==========

Marginal reticular cells are a unique stromal cell subset common to SLOs. MRCs are clearly different from conventional subsets that are induced or maturated through interactions with lymphocytes after birth, and are directly derived from LTo stromal cells in the anlagen and independent of lymphocytes. The network of MRCs is closely associated with the antigen-transporting apparatus of SLOs and is thought to directly or indirectly control antigen delivery to lymphocyte compartments as well as the localization and migration of immune cells. MRCs likely play pivotal roles in maintaining SLO structures as the outer framework and may be converted to other stromal subsets at steady state or during tissue remodeling. It will be important to collectively consider all the stromal subsets, tissue structures, and immunological microenvironments in order to comprehensively understand the SLO system.
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